Key result
Screening of Korean cases with autosomal dominant non-syndromic hearing loss identified four novel heterozygous mutations in MYO6 and one missense variant in MYO1A with deleterious functional effects.
Observational
Identified novel pathogenic mutations in MYO6 and MYO1A associated with autosomal dominant non-syndromic hearing loss in a Korean population, supported by in vitro functional evidence.
May inform future Korean ADNSHL panels; leaves open broader validation and generalizability.
Mutations in five unconventional myosin genes have been associated with genetic hearing loss (HL). These genes encode the motor proteins myosin IA, IIIA, VI, VIIA and XVA. To date, most mutations in myosin genes have been found in the Caucasian population. In addition, only a few functional studies have been performed on the previously reported myosin mutations. We performed screening and functional studies for mutations in the MYO1A and MYO6 genes in Korean cases of autosomal dominant non-syndromic HL. We identified four novel heterozygous mutations in MYO6. Three mutations (p.R825X, p.R991X and Q918fsX941) produce a premature truncation of the myosin VI protein. Another mutation, p.R205Q, was associated with diminished actin-activated ATPase activity and actin gliding velocity of myosin VI in an in vitro analysis. This finding is consistent with the results of protein modelling studies and corroborates the pathogenicity of this mutation in the MYO6 gene. One missense variant, p.R544W, was found in the MYO1A gene, and in silico analysis suggested that this variant has deleterious effects on protein function. This finding is consistent with the results of protein modelling studies and corroborates the pathogenic effect of this mutation in the MYO6 gene.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2014) conducted an observational in Autosomal dominant non-syndromic hearing loss. MYO1A and MYO6 gene mutations was evaluated on Identification of novel mutations and their functional effects. Screening of Korean cases with autosomal dominant non-syndromic hearing loss identified four novel heterozygous mutations in MYO6 and one missense variant in MYO1A with deleterious functional effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: